IX LAYER Inc.

ATHERTON, CA · Founded 2017 · Digital health · Private

Direct-to-patient software platform with integrated AI for biopharma patient engagement and care coordination

Claim this profile

Follows are private to you and power your alerts

Updated · ixlayer.com

Sector
Digital health
Headquarters
ATHERTON, CA
Founded
2017
Latest Form D
$61.3M, Mar 2021
Total capital
$61.3M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$61.3M
1 Form D · last Mar 2021
68 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
6 pending

Capital timeline

2021FEDERAL ↑EQUITY ↓Cumulative $61.3M1st Form D$61.3M
2021FEDERAL ↑EQUITY ↓Cumulative $61.3M1st Form D$61.3M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$61.3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Poorya SabounchiDirectorNamed in SEC Form D filings
  • Pouria SanaeExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 6
  • PendingSystems And Methods For Access Management And Clustering Of Genomic, Phenotype, And Diagnostic DataUSPTOApplication 17963651
  • PendingSystems And Methods For Access Management And Clustering Of Genomic Or Phenotype DataUSPTOApplication 17380563
  • PendingSystems And Methods For Access Management And Clustering Of Genomic, Phenotype, And Diagnostic DataUSPTOApplication PCTUS2021025948
Show all 6 patent records
  • Systems And Methods For Access Management And Clustering Of Genomic, Phenotype, And Diagnostic DataApr 13, 2023 · Application 17963651Pending
  • Systems And Methods For Access Management And Clustering Of Genomic Or Phenotype DataJan 13, 2022 · Application 17380563Pending
  • Systems And Methods For Access Management And Clustering Of Genomic, Phenotype, And Diagnostic DataApplication PCTUS2021025948Pending
  • Systems and Methods for Access Management and Clustering of Genomic, Phenotype, and Diagnostic DataApplication 63011108Pending
  • Systems And Methods For Access Management And Clustering Of Genomic Or Phenotype DataApplication PCTUS2020014471Pending
  • Systems and Methods for Sharing Genomic or Phenotype Data AccessApplication 62795283Pending
  • Patheous Health, Inc.Similar federal contract value in Digital health · null in contracts
  • PharmD Live CorpSimilar federal contract value in Digital health · null in contracts
  • Mandolin Software, Inc.Similar federal contract value in Digital health · null in contracts
  • BEKHealth CorpSimilar federal contract value in Digital health · null in contracts
  • OnPoint Healthcare Partners, Inc.Similar federal contract value in Digital health · null in contracts
  • Finerpoint, Inc.Similar federal contract value in Digital health · null in contracts

Regulatory activity · Digital health

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .